Julie B. Feder, Chief Financial Officer at Aura Biosciences, Inc. (AURA), sold 13,218 shares at $7.64 ($101K) on 2024-01-23, disclosed to the SEC on 2024-01-24.
Open-market sale of $101k AURA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.64 | 6,609 | $50K | 50.0% |
| 2 | $7.64 | 6,609 | $50K | 50.0% |
| Total | $7.64 avg | 13,218 | $101K | 100% |
| Filing → |
| AURA | SELL | 2023-11-01 | $23K | — | Filing → |
| AURA | SELL | 2022-11-02 | $25K | — | Filing → |